Alyeska Investment Group, L.P. 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:37 pm Sale | 2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS | Alyeska Investment Group, L.P. | 146,472 4.800% | -140,599 (-48.98%) | Filing |
| 2024-02-14 1:53 pm Purchase | 2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Alyeska Investment Group, L.P. | 287,071 9.990% | 287,071 (New Position) | Filing |